Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom's Plan to Develop Next-Gen Sequencing Platform Topped Most-Read GenomeWeb Daily News Stories Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Sept. 28.
1. Sequenom Licenses Nanopore Technology from Harvard to Develop 'Third Generation' Sequencer (from Sept. 25)
2. Newsham Genetics To Acquire Monsanto Genomics Unit (from Sept. 26)
3. Abbott Licenses Epigenomics' Methylation Biomarker IP for Cancer IVD (from Sept. 26)
4. Holden to Leave Illumina; Yousaf Tapped to Head ABI’s MCB Systems Group; NIGMS Appoints Lee as Executive Officer, and Others (from Sept. 28)
5. Affymetrix Partners with Navigenics to Offer Personal Genetics Service (from Sept. 27)
The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.